Section 27.30. Reporting cases of certain diseases in the newborn child

Reports of congenital adrenal hyperplasia (CAH), galactosemia, maple syrup urine disease, phenylketonuria, primary congenital hypothyroidism and sickle cell disease shall be made to the Division of Newborn Disease Prevention and Identification, Bureau of Family Health, as specified in Chapter 28 (relating to screening and follow-up for diseases of the newborn) and those provisions of § 27.4 (relating to reporting cases) consistent with Chapter 28 and this section.

The provisions of this § 27.30 adopted January 27, 1978, effective January 28, 1978, 8 Pa.B. 248; amended March 28, 1980, effective March 29, 1980, 10 Pa.B. 1387; amended January 25, 2002, effective January 26, 2002, 32 Pa.B. 491; amended May 17, 2002, effective May 18, 2002, 32 Pa.B. 2435. Immediately preceding text appears at serial pages (287142) to (287143).

Notation

Authority

The provisions of this § 27.30 amended under section 16(a) of the Disease Control and Prevention Act of 1955 (35 P. S. § 521.16(a)); sections 2102(g) and 2111(b) of The Administrative Code of 1929 (71 P. S. § § 532(g) and 541(b)); and sections 3 and 5 of the Newborn Child Testing Act (35 P. S. § § 623 and 625).

Cross References

This section cited in 28 Pa. Code § 27.22 (relating to reporting of cases by clinical laboratories).